Blood gases and retinopathy of prematurity: the ELGAN Study
- PMID: 20689332
- PMCID: PMC2939988
- DOI: 10.1159/000308454
Blood gases and retinopathy of prematurity: the ELGAN Study
Abstract
Objective: This study tested the hypothesis that preterm infants who had a blood gas derangement on at least 2 of the first 3 postnatal days are at increased risk for more severe retinopathy of prematurity (ROP).
Method: 1,042 infants born before 28 weeks' gestational age (GA) were included. An infant was considered to be exposed if his/her blood gas measure was in the highest or lowest quartile for GA on at least 2 of the first 3 postnatal days.
Results: Multivariable models adjusting for confounders indicate that exposure to a PCO(2) in the highest quartile predicts ROP (stage 3, 4 or 5: OR = 1.6, 95% CI = 1.1-2.3); zone 1: 2.0, 1.1-3.6; prethreshold/threshold: 1.9, 1.2-3.0; plus disease: 1.8, 1.1-2.9). Estimates are similar for a low pH for zone 1 (2.1, 1.2-3.8), prethreshold/threshold (1.8, 1.1-2.8), but did not quite achieve statistical significance for ROP stage 3, 4, or 5 (1.4, 0.9-2.0) and plus disease (1.5, 0.9-2.4). A PaO(2) in the highest quartile for GA on at least 2 of the first 3 postnatal days was associated with a doubling of the risk of ROP in zone 1 (2.5, 1.4-4.4) and of prethreshold/threshold disease (2.1, 1.4-3.3), a 70% risk increase for plus disease (1.7, 1.04-2.8), while a 40% risk increase for ROP stage 3 or higher did not achieve statistical significance (1.4, 0.96-2.0).
Conclusion: Infants exposed to high PCO(2), low pH and high PaO(2) appear to be at increased risk of more severe ROP.
Copyright © 2010 S. Karger AG, Basel.
Figures

Similar articles
-
Neonatal bacteremia and retinopathy of prematurity: the ELGAN study.Arch Ophthalmol. 2011 Dec;129(12):1555-63. doi: 10.1001/archophthalmol.2011.319. Arch Ophthalmol. 2011. PMID: 22159674
-
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.Pediatrics. 2000 Feb;105(2):295-310. doi: 10.1542/peds.105.2.295. Pediatrics. 2000. PMID: 10654946 Clinical Trial.
-
Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation >94% in room air: the high oxygen percentage in retinopathy of prematurity study.Pediatrics. 2002 Sep;110(3):540-4. doi: 10.1542/peds.110.3.540. Pediatrics. 2002. PMID: 12205257
-
Postnatal Cerebral Hyperoxia Is Associated with an Increased Risk of Severe Retinopathy of Prematurity.Neonatology. 2019;116(4):356-362. doi: 10.1159/000501859. Epub 2019 Sep 5. Neonatology. 2019. PMID: 31487704 Free PMC article.
-
No clinical correlation between bilirubin levels and severity of retinopathy of prematurity.J Pediatr Ophthalmol Strabismus. 2002 May-Jun;39(3):151-6. doi: 10.3928/0191-3913-20020501-06. J Pediatr Ophthalmol Strabismus. 2002. PMID: 12051280
Cited by
-
Survival rate dependent variations in retinopathy of prematurity treatment rates in very low birth weight infants.Sci Rep. 2020 Nov 10;10(1):19401. doi: 10.1038/s41598-020-76472-w. Sci Rep. 2020. PMID: 33173128 Free PMC article.
-
Blood flow assessed by color Doppler imaging in retinopathy of prematurity.J Perinatol. 2015 Sep;35(9):745-7. doi: 10.1038/jp.2015.45. Epub 2015 May 7. J Perinatol. 2015. PMID: 25950917
-
A Causally Naïve and Rigid Population Model of Disease Occurrence Given Two Non-Independent Risk Factors.Online J Public Health Inform. 2018 Sep 21;10(2):e216. doi: 10.5210/ojphi.v10i2.9357. eCollection 2018. Online J Public Health Inform. 2018. PMID: 30349634 Free PMC article.
-
Current concepts of oxygen management in retinopathy of prematurity.J Ophthalmic Vis Res. 2014 Jan;9(1):94-100. J Ophthalmic Vis Res. 2014. PMID: 24982738 Free PMC article.
-
Antimicrobial peptides modulate lung injury by altering the intestinal microbiota.Microbiome. 2023 Oct 16;11(1):226. doi: 10.1186/s40168-023-01673-0. Microbiome. 2023. PMID: 37845716 Free PMC article.
References
-
- Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia: a clinical approach. Med J Aust. 1951;2:48–50. - PubMed
-
- Patz A, Hoeck LE, De La Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol. 1952;35:1248–1253. - PubMed
-
- Gibson DL, Sheps SB, Uh SH, Schechter MT, McCormick AQ. Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic. Pediatrics. 1990;86:405–412. - PubMed
-
- Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1991;98:1628–1640. - PubMed
-
- McColm JR, Fleck BW. Retinopathy of prematurity: causation. Semin Neonatol. 2001;6:453–460. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical